BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8172284)

  • 41. Optic nerve sheath decompression with adjunctive mitomycin and Molteno device implantation.
    Spoor TC; McHenry JG; Shin DH
    Arch Ophthalmol; 1994 Jan; 112(1):25-6. PubMed ID: 8285887
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression.
    Anderson RL; Flaharty PM
    Am J Ophthalmol; 1992 May; 113(5):599-601. PubMed ID: 1575245
    [No Abstract]   [Full Text] [Related]  

  • 43. Optic nerve sheath decompression: history, techniques, and indications.
    Sergott RC
    Int Ophthalmol Clin; 1991; 31(4):71-81. PubMed ID: 1743897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optic nerve sheath fenestration for vision preservation in idiopathic intracranial hypertension.
    Agarwal MR; Yoo JH
    Neurosurg Focus; 2007; 23(5):E7. PubMed ID: 18004969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optic nerve sheath decompression: a surgical technique with minimal operative complications.
    Moreau A; Lao KC; Farris BK
    J Neuroophthalmol; 2014 Mar; 34(1):34-8. PubMed ID: 24275984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optic nerve sheath fenestration in patients with visual failure associated with vestibular schwannoma.
    Jefferis JM; Raoof N; Carroll T; Salvi SM
    Br J Neurosurg; 2019 Aug; 33(4):402-408. PubMed ID: 30829548
    [No Abstract]   [Full Text] [Related]  

  • 47. Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension.
    Tarrats L; Hernández G; Busquets JM; Portela JC; Serrano LA; González-Sepúlveda L; Sánchez-Pérez JR
    Int Forum Allergy Rhinol; 2017 Jun; 7(6):615-623. PubMed ID: 28383199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benign intracranial hypertension: visual loss and optic nerve sheath fenestration.
    Knight RS; Fielder AR; Firth JL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):243-50. PubMed ID: 3958737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Commentary: Endoscopic Endonasal Optic Nerve Decompression in Idiopathic Intracranial Hypertension: When to Implement Optic Nerve Sheath Fenestration.
    Prabhu VC; Serrone JC; Thakkar JP; Yoo DK; Germanwala AV
    Oper Neurosurg (Hagerstown); 2023 Oct; 25(4):e194-e195. PubMed ID: 37441798
    [No Abstract]   [Full Text] [Related]  

  • 50. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.
    Wilkes BN; Siatkowski RM
    J Neuroophthalmol; 2009 Dec; 29(4):281-3. PubMed ID: 19952899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bilateral retinal venous caliber decrease following unilateral optic nerve sheath decompression.
    Lee SY; Shin DH; Spoor TC; Kim C; McCarty B; Kim D
    Ophthalmic Surg; 1995; 26(1):25-8. PubMed ID: 7746620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracranial pressure following optic nerve decompression for benign intracranial hypertension. Case report.
    Kaye AH; Galbraith JE; King J
    J Neurosurg; 1981 Sep; 55(3):453-6. PubMed ID: 7264736
    [No Abstract]   [Full Text] [Related]  

  • 53. Choroidal infarction after optic nerve sheath fenestration.
    Rizzo JF; Lessell S
    Ophthalmology; 1994 Sep; 101(9):1622-6. PubMed ID: 8090466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visual improvement after optic nerve sheath decompression in a case of congenital hydrocephalus and persistent visual loss despite intracranial pressure correction via shunting.
    Carruth BP; Bersani TA; Hurley PE; Ko MW
    Ophthalmic Plast Reconstr Surg; 2010; 26(4):297-8. PubMed ID: 20551858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optic nerve sheath fenestration for treatment of progressive ischemic optic neuropathy.
    McHenry JG; Spoor TC
    Arch Ophthalmol; 1993 Dec; 111(12):1601-2. PubMed ID: 8155021
    [No Abstract]   [Full Text] [Related]  

  • 56. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri.
    Liu GT; Glaser JS; Schatz NJ
    Am J Ophthalmol; 1994 Jul; 118(1):88-96. PubMed ID: 8023881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optic nerve sheath decompression for visual loss in patients with acquired immunodeficiency syndrome and cryptococcal meningitis with papilledema.
    Garrity JA; Herman DC; Imes R; Fries P; Hughes CF; Campbell RJ
    Am J Ophthalmol; 1993 Oct; 116(4):472-8. PubMed ID: 8213978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unilateral blindness after ipsilateral prophylactic transcranial optic canal decompression for fibrous dysplasia.
    Edelstein C; Goldberg RA; Rubino G
    Am J Ophthalmol; 1998 Sep; 126(3):469-71. PubMed ID: 9744390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optic nerve sheath decompression. How does it work? Has its time come?
    Keltner JL
    Arch Ophthalmol; 1988 Oct; 106(10):1365-9. PubMed ID: 3052381
    [No Abstract]   [Full Text] [Related]  

  • 60. [Decompression of the optic nerve sheath].
    Adenis JP; Salomon JL
    J Fr Ophtalmol; 1993; 16(5):353-60. PubMed ID: 8331257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.